Circulating Tumor Cells and Plasma DNA Analysis in Patients with Indeterminate Early or Metastatic Breast Cancer

Abstract

Both CTC and plasma DNA analyses together suggested that these patients had little evidence of metastatic disease. Future studies will be designed to assess the utility of these biomarkers in the follow-up of a larger number of women with breast cancer.